blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1843159

EP1843159 - Use of Transthyretin (prealbumin) as a biomarker for colorectal carcinoma; Method for detection and test system [Right-click to bookmark this link]
Former [2007/41]Use of Transthyretin as a biomarker for colorectal adenoma and /or carcinoma; Method for detection and test system
[2007/43]
StatusThe application is deemed to be withdrawn
Status updated on  26.06.2009
Database last updated on 31.08.2024
Most recent event   Tooltip26.06.2009Application deemed to be withdrawnpublished on 29.07.2009  [2009/31]
Applicant(s)For all designated states
Indivumed GmbH
Orchideenstieg 14
22297 Hamburg / DE
[2007/41]
Inventor(s)01 / Juhl, Hartmut Prof.
Nienstedtener Strasse 18
22609 Hamburg / DE
02 / David, Kerstin Dr.
Chateauneufstrasse 10
20535 Hamburg / DE
 [2008/37]
Former [2008/22]01 / Juhl, Hartmut Prof.
Kurt-Küchler-Straße 5
22609 Hamburg / DE
02 / David, Kerstin Dr.
Chateauneufstrasse 10
20535 Hamburg / DE
Representative(s)Louis Pöhlau Lohrentz
Patentanwälte
Postfach 30 55
90014 Nürnberg / DE
[N/P]
Former [2007/41]LOUIS, PÖHLAU, LOHRENTZ
Postfach 30 55
90014 Nürnberg / DE
Application number, filing date07014481.113.08.2004
[2007/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1843159
Date:10.10.2007
Language:EN
[2007/41]
Search report(s)(Supplementary) European search report - dispatched on:EP06.09.2007
ClassificationIPC:G01N33/574
[2007/41]
CPC:
G01N33/57419 (EP,KR,US); G01N33/57488 (EP,KR,US); G01N33/78 (EP,KR,US);
G01N2333/76 (EP,KR,US); G01N2800/52 (EP,KR,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/41]
TitleGerman:Verwendung von Transthyretin (prealbumin) als Biomarker für Kolorektalkarzinome sowie Verfahren für Erkennung und Prüfsystem[2007/43]
English:Use of Transthyretin (prealbumin) as a biomarker for colorectal carcinoma; Method for detection and test system[2007/43]
French:Utilisation de Transthyretin (prealbumin) comme biomarquer du carcinome colorectal; procédés de detection et système de test[2007/43]
Former [2007/41]Verwendung von Transthyretin als Biomarker für Kolorektaladenome und /oder karzinome sowie Verfahren für deren Erkennung und Prüfsystem
Former [2007/41]Use of Transthyretin as a biomarker for colorectal adenoma and /or carcinoma; Method for detection and test system
Former [2007/41]Utilisation de Transthyretin (prealbumin) comme biomarqueur du carcinome colorectal; procédés de detection et système de test
Examination procedure24.07.2007Examination requested  [2007/41]
20.05.2008Despatch of a communication from the examining division (Time limit: M08)
09.09.2008Observations by third parties
02.02.2009Application deemed to be withdrawn, date of legal effect  [2009/31]
10.03.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/31]
Parent application(s)   TooltipEP04764118.8  / EP1761779
Fees paidRenewal fee
24.07.2007Renewal fee patent year 03
24.07.2007Renewal fee patent year 04
28.03.2008Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2004012588  (UNIV JOHNS HOPKINS [US], et al) [X] 25-27* page 7, line 19 *;
 [XY]  - BASU T K ET AL, "BIOCHEMICAL STATUS OF VITAMIN A IN COLORECTAL CANCER", JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, (1991), vol. 10, no. 1, ISSN 0912-0009, pages 65 - 70, XP009088521 [X] 1-27 * abstract * [Y] 1-27
 [X]  - BULLEN B R ET AL, "CANCER MARKERS IN PATIENTS RECEIVING CHEMO THERAPY FOR COLO RECTAL CANCER A PRELIMINARY REPORT", MEDICAL AND PEDIATRIC ONCOLOGY, (1977), vol. 3, no. 3, ISSN 0098-1532, pages 289 - 300, XP009088518 [X] 1-27 * the whole document *
 [Y]  - GU J-R ET AL, "TRANSTHYRETIN (PREALBUMIN) GENE IN HUMAN PRIMARY HEPATIC CANCER", SCIENCE IN CHINA SERIES B. CHEMISTRY, LIFE SCIENCES AND EARTH SCIENCES, (199111), vol. 34, no. 11, ISSN 1001-652X, pages 1312 - 1318, XP000904539 [Y] 1-27 * abstract *
 [Y]  - ZHANG ZHEN ET AL, "Transthyretin variants as potential biomarkers for the detection of early stage ovarian cancer.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, & 95TH ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-FOR-CANCER-RESEARCH; ORLANDO, FL, USA; MARCH 27 -31, 2004, (200403), vol. 45, ISSN 0197-016X, page 1303, XP001536542 [Y] 8,11,20 * abstract *
 [Y]  - YÜCEYAR S ET AL, "The role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19-9 as a marker in the preoperative staging of colorectal cancer: a prospective clinical study.", INTERNATIONAL SURGERY 1996 APR-JUN, (199604), vol. 81, no. 2, ISSN 0020-8868, pages 136 - 139, XP009088520 [Y] 12,13,22,23 * abstract *
otherWO2004013609
    - HOLLINSHEAD A.C. AND C_Y: CHUANG, "Evaluation of the Relationships pf Prealbumin Components in Sera of Patients with cancer.", NATL. CANCER. INST. MONOGR., (1978), vol. 49, pages 187 - 192, XP003023179
    - MILANO G. ET AL, "Serum prealbumin, Retinol-Binding protein, transferrin, and albumin levels in patients with large bowel cancer", J. NATL. CANCER INST., (1978), vol. 61, pages 687 - 691, XP003023180
    - ROBOZ J., "Identification of putative colon cancer protein biomarker by mass spectrometry", PROC. AMER. ASOC. CANCER RESEARCH, (20040305), vol. 45, pages 1 - 2, XP003023181
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.